English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Biospace

Patient Daily | Dec 8, 2025

CDC advisory panel to review hepatitis B vaccine schedule under new chair Kirk Milhoan

Patient Daily | Dec 8, 2025

Imvax moves forward with FDA plans for glioblastoma drug after survival gain

Patient Daily | Dec 8, 2025

Biotechs move away from troubled Novo Nordisk plant amid FDA scrutiny

Patient Daily | Dec 5, 2025

Eisai remains optimistic about Alzheimer's drug despite industry setbacks

Patient Daily | Dec 4, 2025

FDA says report on alleged child deaths tied to COVID-19 vaccines coming by month’s end

Patient Daily | Dec 4, 2025

Biopharma job postings rise for second month as application rates also climb

Patient Daily | Dec 3, 2025

Capricor reports positive phase III results for DMD cardiomyopathy therapy after initial FDA rejection

Patient Daily | Dec 3, 2025

FDA proposes reducing primate use in antibody therapy testing

Trending

Patient Daily | Mar 6, 2026

Dallas Breathe Free ranked top ENT practice in region by reviewers on Google

+ Regulatory
Patient Daily | Mar 5, 2026

TPA Director: RFK Jr.'s 'latest ideological crusade would be great for trial lawyers, but terrible for millions of patients'

+ Pharmaceuticals
Patient Daily | Mar 7, 2026

FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others

+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'

  • « First
  • «
  • …
  • 20
  • 21
  • 22
  • 23


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily